/
/
Flöde flödescytometri-baserade Drug Screening System för identifiering av små molekyler som främjar celldifferentiering av Glioblastoma stamceller
A subscription to JoVE is required to view this content. Sign in or start your free trial.
1Department of Neurological Surgery, Case Comprehensive Cancer Center,Case Western Reserve University School of Medicine, 2Department of Pathology,Johns Hopkins University, School of Medicine, 3Department of Neurological Surgery, University Hospital-Case Medical Center, Case Comprehensive Cancer Center,Case Western Reserve University School of Medicine
Chapters
- 00:05Title
- 01:17Generation of Lentiviral Transcriptional Reporter Cell Lines
- 03:47Subclone Selection, Expansion, and Validation
- 04:47Determination of GFAP:GFP Expression by Flow Cytometry
- 05:58ELDA Self-renewal Assay to Assess Clonogenic Capacity
- 07:01Drug Screen
- 08:27Results: Selection and Drug Screening of Glioblastoma Stem Cell Subclones
- 09:46Conclusion
En effektiv screening protokoll presenteras för identifiering av små molekyler som främjar astroglial differentiering i glioblastoma stamceller (GSCs). Analysen är baserad på stamcells differentiering reporter varvid uttrycket av den förbättrade GFP (andra) drivs av mänskliga Fredsgenomförande arrangören.
Tags
Flow CytometryDrug ScreeningGlioblastoma Stem CellsCellular DifferentiationLentivirusReporter ConstructHigh-throughput ScreeningSmall MoleculesAstroglial DifferentiationCancer Stem CellsEhlers-Danlos GlioblastomaCell LineageBloodborne PathogensNeural Stem Cell Growth MediumPolybreneDissociation Reagent
